These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34552824)

  • 21. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
    Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W
    Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
    Wang S; Jia M; He Z; Liu XS
    Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancer.
    Li S; Sun S; Sun H; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Wang W; Li Z; Ma Y; Xue Y; Zhao Y
    Int Immunopharmacol; 2021 Jul; 96():107589. PubMed ID: 34162126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-infiltrating podoplanin
    Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H
    Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.
    Zhang X; Wu Z; Hao Y; Yu T; Li X; Liang Y; Li J; Huang L; Xu Y; Li X; Xu X; Wang W; Xu G; Zhang X; Lv Q; Fang Y; Xu R; Qian W
    Front Immunol; 2022; 13():888250. PubMed ID: 35592333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of APOBEC3B in chondrosarcoma.
    Jin Z; Han YX; Han XR
    Oncol Rep; 2014 Nov; 32(5):1867-72. PubMed ID: 25176183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral CXCL13
    Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3B: a potential factor suppressing growth of human hepatocellular carcinoma cells.
    Wu PF; Chen YS; Kuo TY; Lin HH; Liu CW; Chang LC
    Anticancer Res; 2015 Mar; 35(3):1521-7. PubMed ID: 25750306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.
    Sieuwerts AM; Willis S; Burns MB; Look MP; Meijer-Van Gelder ME; Schlicker A; Heideman MR; Jacobs H; Wessels L; Leyland-Jones B; Gray KP; Foekens JA; Harris RS; Martens JW
    Horm Cancer; 2014 Dec; 5(6):405-13. PubMed ID: 25123150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfavorable prognosis and clinical consequences of APOBEC3B expression in breast and other cancers: A systematic review and meta-analysis.
    Jafarpour S; Yazdi M; Nedaeinia R; Ghobakhloo S; Salehi R
    Tumour Biol; 2022; 44(1):153-169. PubMed ID: 36093650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
    Wang JT; Li H; Zhang H; Chen YF; Cao YF; Li RC; Lin C; Wei YC; Xiang XN; Fang HJ; Zhang HY; Gu Y; Liu X; Zhou RJ; Liu H; He HY; Zhang WJ; Shen ZB; Qin J; Xu JJ
    Ann Oncol; 2019 Feb; 30(2):266-273. PubMed ID: 30445581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy.
    Gu Y; Zhang P; Wang J; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2023 May; 72(5):1199-1208. PubMed ID: 36369379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Fujiki Y; Yamamoto Y; Sueta A; Yamamoto-Ibusuki M; Goto-Yamaguchi L; Tomiguchi M; Takeshita T; Iwase H
    Oncotarget; 2018 Jul; 9(55):30513-30526. PubMed ID: 30093965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of APOBEC3B in mutation induction by irradiation.
    Saito Y; Miura H; Takahashi N; Kuwahara Y; Yamamoto Y; Fukumoto M; Yamamoto F
    J Radiat Res; 2020 Nov; 61(6):819-827. PubMed ID: 32880638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.